NEURODEVELOPMENTAL DISORDERS & COPY NUMBER VARIANTS: GENETIC INSIGHTS INTO BEHAVIOR AND COGNITION

“ℝ𝕒𝕣𝕖 𝕔𝕠𝕡𝕪 𝕟𝕦𝕞𝕓𝕖𝕣 𝕧𝕒𝕣𝕚𝕒𝕟𝕥𝕤 𝕡𝕝𝕒𝕪 𝕒 𝕤𝕚𝕘𝕟𝕚𝕗𝕚𝕔𝕒𝕟𝕥 𝕣𝕠𝕝𝕖 𝕚𝕟 𝕥𝕙𝕖 𝕘𝕖𝕟𝕖𝕥𝕚𝕔 𝕒𝕣𝕔𝕙𝕚𝕥𝕖𝕔𝕥𝕦𝕣𝕖 𝕠𝕗 𝕒𝕦𝕥𝕚𝕤𝕞 𝕒𝕟𝕕 𝕠𝕥𝕙𝕖𝕣 𝕟𝕖𝕦𝕣𝕠𝕕𝕖𝕧𝕖𝕝𝕠𝕡𝕞𝕖𝕟𝕥𝕒𝕝 𝕕𝕚𝕤𝕠𝕣𝕕𝕖𝕣𝕤.” - Professor Evan Eichler

🧬 Neurodevelopmental disorders (NDDs) including autism, ADHD, and intellectual disability arise from early disruptions in brain development & affect almost 15% of children globally. Their origins are multifactorial, but genetic architecture is increasingly recognised as a central driver, particularly the role of copy number variants (CNVs).
           🔹CNVs are structural genomic alterations involving the deletion or duplication of DNA segments. Although common in the population, certain rare CNVs significantly alter gene dosage, disrupt regulatory elements, or impair neural pathways, increasing susceptibility to NDDs. Robust evidence links CNVs at 22q11.2, 16p11.2, 1q21.1, 7q11.23, & others with autism, schizophrenia, Williams syndrome, & developmental delay. Individuals with NDDs carry a higher burden of rare CNVs compared to neurotypical populations, and specific CNVs often correlate with distinct phenotypic profiles, supporting precision-based classification of NDD subtypes.

For example:

16p11.2 deletions → language delay, motor deficits

15q11.2-13 duplications → autism and seizures

22q13 (SHANK3) deletions → Phelan-McDermid syndrome with synaptic dysfunction.

         🔹 CNVs influence neurodevelopment 🧠 through altered gene dosage affecting neuronal differentiation, disruption of synaptic scaffolding proteins (e.g., SHANK3), impaired neurotransmitter signalling, and cascading effects on brain circuits supporting cognition, learning, and behavior. The polygenic and environment-dependent nature of CNVs highlights why NDDs present with such broad variability.

         🔹Advances in genomic technologies now allow early detection of pathogenic CNVs, phenotype-informed prognosis, movement toward precision-guided interventions, and development of pharmacogenetic approaches designed to molecular pathways affected by specific CNVs.

         ➡️ Integrating genomics with neuroimaging and behavioural profiling promises a future where NDD care is precised, proactive, & targeted.

⚠️ In an Oystershell, CNVs provide powerful insights into the biological underpinnings of neurodevelopmental disorders. As research uncovers their mechanisms and impacts, genetics will continue to transform how we diagnose, stratify, and ultimately treat NDDs.

Abubakar Abubakar ✍🏻

• Sanders SJ et al. Cell (2015).

• Eichler EE et al. Nature Reviews Genetics (2010).

• Cooper GM et al. Nature Genetics (2011).

• Phelan K & McDermid HE. Mol Syndromol (2012).

#AutismResearch #Neurogenetics #GeneticMedicine #PrecisionMedicine #Neuroscience #ClinicalGenetics #MolecularGenetics #CNVs #RareDiseases #NGS #CRISPR⚕️